production of their medicine. Their products are certified by the most important pharmaceutical regulatory authorities in the world; namely, WHO, USFDA, MHRA,UK, EMEA, ORGANIZACION PANAMERICANA DE LA SALUD, and INVIMA. HB Human BioScience imports the best medicine products from the most recognized laboratories around the world. HB Human BioScience also develops molecules to create its own medicines and introduce them into de pharmaceutical industry. HB Human BioSience specializes also in “Orphan Drugs” which are pharmaceutical agents that have been developed specifically to treat rare medical conditions, referred to as an” orphan diseases”. Due to their low returns or high costs many “Orphan drugs” are not always available or sufficient in many countries. Orphan Diseases are rare diseases with an average prevalence of less than 5 cases per 10,000 inhabitants. These are usually genetic diseases and/or life threatening conditions. Today certain drugs exist for those treatments however due to the rarity of the diseases it is usually impractical to procure licenses to import however Human Bioscience has implemented an infrastructure to deliver these medicines to thousands of patients worldwide who are suffering from these conditions. Other fields in which HB Human Bioscience stands out are in the development of Active Principles, Bioequivalences and New Medicines. Towards this end HB Human Bioscience works closely with a great team of prestigious scientists who apply their knowledge and technology to produce better and safer medicines to heal or prolong the life of thousands of patients.